Rebranding MS as a Dementia: part 2

"What do you think of this of short animation? It tries to explain the impact of MS on the brain; in the other words the early phases of MS Dementia."

Disclaimer: This animation is part of a series of animations on a MSer website, called "MS and Our Story"; I note the site is sponsored by Novartis. Novartis are a Pharma Company that produce and market a drug called Gilenya (Fingolimod) that is licensed to treat relapsing forms of MS.

"Should we rebrand MS as dementia? Have your say?"

Labels: ,